SERUM-FREE MEDIUM FOR FULL SUSPENSION CULTURE OF MDCK CELLS AND PREPARATION METHOD OF SERUM-FREE MEDIUM

Abstract

The present invention discloses a serum-free medium for full suspension culture of MDCK cells and a preparation method of the serum-free medium. The serum-free medium for full suspension culture of the MDCK cells comprises basic metabolic nutrients, nucleotide, vitamins, inorganic salts, a shear force protective agent, a cell clustering resisting agent, a pH buffer agent, a pH indicator, an influenza virus proliferation accelerant and other additives. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells comprises the following steps: 1) preparing a mixed solution: dissolving and mixing raw materials; and 2) regulating pH: regulating the pH of the mixed solution to 6.3 to 6.7, and setting a constant volume to obtain the serum-free medium for the full suspension culture of the MDCK cells. The medium supports the high-density full-suspension culture of the MDCK single cells, greatly shortens a time for educating the MDCK cells from adherent cells into the serum-free full suspension cells, and is applicable to the mass production of biological products, and particularly veterinary biological products.

Claims

1. A serum-free medium for full suspension culture of MDCK cells, comprising components of the following concentrations: basic metabolic nutrients: TABLE-US-00059 D-glucose 3000 to 10000 mg/L; sodium pyruvate 50 to 600 mg/L; L-alanine 5 to 30 mg/L; L-arginine 150 to 600 mg/L; L-asparagine 10 to 60 mg/L; L-aspartic acid 10 to 60 mg/L; L-cystine 10 to 80 mg/L; L-cysteine 20 to 150 mg/L; L-glutamic acid 5 to 60 mg/L; L-glutamine 300 to 1500 mg/L; glycine 10 to 100 mg/L; L-histidine 10 to 150 mg/L; L-isoleucine 20 to 150 mg/L; L-leucine 50 to 250 mg/L; L-lysine 50 to 150 mg/L; L-methionine 20 to 150 mg/L; L-phenylalanine 20 to 250 mg/L; L-proline 20 to 200 mg/L; L-serine 50 to 150 mg/L; L-threonine 50 to 200 mg/L; L-tryptophan 20 to 100 mg/L; L-tyrosine 20 to 100 mg/L; L-valine 50 to 200 mg/L; nucleotide: TABLE-US-00060 hypoxanthine 2 to 25 mg/L; thymidine 0.1 to 1 mg/L;  adenosine 2 to 15 mg/L; uridine 2 to 15 mg/L; cytidine 2 to 15 mg/L; guanosine 2 to 15 mg/L; vitamins: TABLE-US-00061 vitamin D 0.01 to 0.20 mg/L; folic acid 1 to 10 mg/L; nicotinamide 1 to 10 mg/L; pyridoxine 1 to 10 mg/L; thiamine 1 to 10 mg/L; riboflavin 0.1 to 1 mg/L; choline chloride 10 to 50 mg/L; D-calcium pantothenate 2 to 10 mg/L; inositol 10 to 50 mg/L; inorganic salts: TABLE-US-00062 ferric nitrate 10 to 50 mg/L; ferrous sulfate 0.1 to 1 mg/L; magnesium sulfate 20 to 100 mg/L; potassium chloride 200 to 500 mg/L; sodium chloride 5000 to 9000 mg/L; disodium hydrogen phosphate 50 to 100 mg/L; sodium dihydrogen phosphate 50 to 100 mg/L; sodium selenite 20 to 100 mg/L; shear force protective agent: 500 to 2500 mg/L; cell clustering resisting agent 20 to 150 mg/L; pH buffer agent: TABLE-US-00063 sodium bicarbonate 1000 to 3000 mg/L; pH indicator: TABLE-US-00064 phenol red 5 to 15 mg/L; influenza virus proliferation accelerant: TABLE-US-00065 cholesterol 1 to 10 mg/L; DL-α-tocopherol acetate 0.3 to 3 mg/L; myristic acid 0.05 to 0.5 mg/L; palmitic acid 0.05 to 0.5 mg/L; stearic acid 0.05 to 0.5 mg/L; magnesium chloride 1000 to 5000 mg/L; calcium chloride 50 to 250 mg/L; dimethyl sulfoxide 2 to 20 mg/L; zinc sulfate 0.2 to 2.0 mg/L; copper sulfate 5 to 25 mg/L; manganese sulfate 0.0001 to 0.001 mg/L; ammonium metavanadate 0.001 to 0.005 mg/L; other additives: TABLE-US-00066 ammonium ferric citrate 13.5 to 40.5 mg/L; insulin 2 to 15 mg/L; soybean hydrolysate 1000 to 5000 mg/L; ethanolamine 1 to 10 mg/L; glutathione 0.5 to 3 mg/L.

2. The serum-free medium for the full suspension culture of the MDCK cells of claim 1, wherein the serum-free medium for the full suspension culture of the MDCK cells comprises components of the following concentrations: basic metabolic nutrients: TABLE-US-00067 D-glucose 4500 mg/L; sodium pyruvate 220 mg/L; L-alanine 22.3 mg/L; L-arginine 273.9 mg/L; L-asparagine 33.9 mg/L; L-aspartic acid 33.3 mg/L; L-cystine 42.67 mg/L; L-cysteine 68.60 mg/L; L-glutamic acid 36.8 mg/L; L-glutamine 876 mg/L; glycine 26.44 mg/L; L-histidine 73.50 mg/L; L-isoleucine 89.52 mg/L; L-leucine 159.38 mg/L; L-lysine 107.21 mg/L; L-methionine 87.74 mg/L; L-phenylalanine 100.38 mg/L; L-proline 96.47 mg/L; L-serine 78.46 mg/L; L-threonine 136.46 mg/L; L-tryptophan 57.81 mg/L; L-tyrosine 56.87 mg/L; L-valine 96.85 mg/L; nucleotide: TABLE-US-00068 hypoxanthine 10.3 mg/L; thymidine 0.24 mg/L; adenosine 7 mg/L; uridine 7 mg/L; cytidine 7 mg/L; guanosine 7 mg/L; vitamins: TABLE-US-00069 vitamin D 0.072 mg/L; folic acid 5.32 mg/L; nicotinamide 3.14 mg/L; pyridoxine 3.15 mg/L; thiamine 3.23 mg/L; riboflavin 0.36 mg/L; choline chloride 26.01 mg/L; D-calcium pantothenate 5.82 mg/L; inositol 25 mg/L; inorganic salts: TABLE-US-00070 ferric nitrate 24.19 mg/L; ferrous sulfate 0.417 mg/L; magnesium sulfate 48.8 mg/L; potassium chloride 311.8 mg/L; sodium chloride 6860 mg/L; disodium hydrogen phosphate 71 mg/L; sodium dihydrogen phosphate 62.5 mg/L; sodium selenite 51.88 mg/L; shear force protective agent: 1600 mg/L; cell clustering resisting agent: 50 mg/L; pH buffer agent: TABLE-US-00071 sodium bicarbonate 2200 mg/L; pH indicator: TABLE-US-00072 phenol red 8 mg/L; influenza virus proliferation accelerant: TABLE-US-00073 cholesterol 3.13 mg/L; DL-α-tocopherol acetate 1.39 mg/L; myristic acid 0.2284 mg/L; palmitic acid 0.256 mg/L; stearic acid 0.285 mg/L; magnesium chloride 2856 mg/L; calcium chloride 174.9 mg/L; dimethyl sulfoxide 11 mg/L; zinc sulfate 0.8 mg/L; copper sulfate 15.97 mg/L; manganese sulfate 0.000302 mg/L; ammonium metavanadate 0.00234 mg/L; other additives: TABLE-US-00074 ammonium ferric citrate 27 mg/L; insulin 6.94 mg/L; soybean hydrolysate 2100 mg/L; ethanolamine 3.46 mg/L; glutathione 1.4 mg/L.

3. The serum-free medium for the full suspension culture of the MDCK cells of claim 1, wherein the shear force protective agent is segmented polyether F68.

4. The serum-free medium for the full suspension culture of the MDCK cells of claim 1, wherein the cell clustering resisting agent is dextran sulfate.

5. A preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 1, comprising the following steps: 1) preparing a mixed solution: dissolving and mixing raw materials in one of the following methods: I) mixing and grinding the raw materials into fine powder, and then dissolving the, obtained fine powder in a solvent at 10 to 30° C. to obtain a mixed solution; II) respectively dissolving the raw materials in the solvent to obtain a raw material solution; and mixing the obtained raw material solutions at a temperature of 10 to 30° C. to obtain a mixed solution; and 2) regulating pH: regulating the pH of the mixed solution to 6.3 to 6.7, and setting a constant volume to obtain the serum-free medium for the full suspension culture of the MDCK cells.

6. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 5, wherein in step 1), the solvent is pyrogen-free ultra-pure water.

7. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 5, wherein in step 2), sodium hydroxide is added to regulate the pH value of the obtained mixed solution.

8. A preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 2, comprising the following steps: 1) preparing a mixed solution: dissolving and mixing raw materials in one of the following methods: I) mixing and grinding the raw materials into fine powder, and then dissolving the obtained fine powder in a solvent at 10 to 30° C. to obtain a mixed solution; II) respectively dissolving the raw materials in the solvent to obtain a raw material solution; and mixing the obtained raw material solutions at a temperature of 10 to 30° C. to obtain a mixed solution; and 2) regulating pH: regulating the pH of the mixed solution to 6.3 to 6.7, and setting a constant volume to obtain the serum-free medium for the full suspension culture of the MDCK cells.

9. The preparation method of the serum-free medium for the full suspension culture, of the MDCK cells of claim 8, wherein in step 1), the solvent is pyrogen-free ultra-pure water.

10. The preparation method of the, serum-free medium for the full suspension culture of the MDCK cells of claim 8, wherein in step 2), sodium hydroxide is added to regulate the pH value of the obtained mixed solution.

11. A preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 3, comprising the following steps: 1) preparing a mixed solution: dissolving and mixing raw materials in one of the following methods: I) mixing and grinding the raw materials into fine powder, and then dissolving the obtained fine powder in a solvent at 10 to 30° C. to obtain a mixed solution; II) respectively dissolving the raw materials in the solvent to obtain a raw material solution; and mixing the obtained raw material solutions at a temperature of 10 to 30° C. to obtain a mixed solution; and 2) regulating pH: regulating the pH of the mixed solution to 6.3 to 6.7, and setting a constant volume to obtain the serum-free medium for the full suspension culture of the MDCK cells.

12. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 11, wherein in step 1), the solvent is pyrogen-free ultra-pure water.

13. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 11, wherein in step 2), sodium hydroxide is added to regulate the pH value of the obtained mixed solution.

14. A preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 4, comprising the following steps: 1) preparing a mixed solution: dissolving and mixing raw materials one of the following methods: I) mixing and grinding the raw materials into fine powder, and then dissolving the obtained fine powder in a solvent at 10 to 30° C. to obtain a mixed solution; II) respectively dissolving the raw materials in the solvent to obtain a raw material solution; and mixing the obtained raw material solutions at a temperature of 10 to 30° C. to obtain a mixed solution; and 2) regulating pH: regulating the pH of the mixed solution to 6.3 to 6.7, and setting a constant volume to obtain the serum-free medium for the full suspension culture of the MDCK cells.

15. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 14, wherein in step 1), the solvent is pyrogen-free ultra-pure water.

16. The preparation method of the serum-free medium for the full suspension culture of the MDCK cells of claim 14, wherein in step 2), sodium hydroxide is added to regulate the pH value of the obtained mixed solution.

Description

DESCRIPTION OF THE DRAWINGS

[0043] FIG. 1 is a curve chart of living cell density and cell activity in embodiment 4;

[0044] FIG. 2 is a graph of morphology of MDCK cells in a serum adherent culture state in embodiment 5;

[0045] FIG. 3 is a graph of morphology of MDCK cells educated with a serum-free medium of the present invention in embodiment 5;

[0046] FIG. 4 is a graph of morphology of suspension cultured MDCKS cells obtained by employing a serum-free medium SFM4 Mega Vir of Hyclone Company in a direct education method in embodiment 5; and

[0047] FIG. 5 is a graph of morphology of MDCK.SUS2 cells obtained by employing a commercial serum-free medium SMIF8 developed by Gibco Company in an indirect education method in embodiment 5.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

[0048] The present invention is further described below in combination with specific implementation manners:

[0049] Specific implementation manners:

[0050] A serum-free medium for full suspension culture of MDCK cells comprises components of the following concentrations:

[0051] basic metabolic nutrients:

TABLE-US-00017 D-glucose 3000 to 10000 mg/L; sodium pyruvate 50 to 600 mg/L; L-alanine 5 to 30 mg/L; L-arginine 150 to 600 mg/L; L-asparagine 10 to 60 mg/L; L-aspartic acid 10 to 60 mg/L; L-cystine 10 to 80 mg/L; L-cysteine 20 to 150 mg/L; L-glutamic acid 5 to 60 mg/L; L-glutamine 300 to 1500 mg/L; glycine 10 to 100 mg/L; L-histidine 10 to 150 mg/L; L-isoleucine 20 to 150 mg/L; L-leucine 50 to 250 mg/L; L-lysine 50 to 150 mg/L; L-methionine 20 to 150 mg/L; L-phenylalanine 20 to 250 mg/L; L-proline 20 to 200 mg/L; L-serine 50 to 150 mg/L; L-threonine 50 to 200 mg/L; L-tryptophan 20 to 100 mg/L; L-tyrosine 20 to 100 mg/L; L-valine 50 to 200 mg/L;

[0052] nucleotide:

TABLE-US-00018 hypoxanthine 2 to 25 mg/L; thymidine 0.1 to 1 mg/L;  adenosine 2 to 15 mg/L; uridine 2 to 15 mg/L; cytidine 2 to 15 mg/L; guanosine 2 to 15 mg/L;

[0053] vitamins:

TABLE-US-00019 vitamin D 0.01 to 0.20 mg/L; folic acid 1 to 10 mg/L; nicotinamide 1 to 10 mg/L; pyridoxine 1 to 10 mg/L; thiamine 1 to 10 mg/L; riboflavin 0.1 to 1 mg/L; choline chloride 10 to 50 mg/L; D-calcium pantothenate 2 to 10 mg/L; inositol 10 to 50 mg/L;

[0054] inorganic salts:

TABLE-US-00020 ferric nitrate 10 to 50 mg/L; ferrous sulfate 0.1 to 1 mg/L; magnesium sulfate 20 to 100 mg/L; potassium chloride 200 to 500 mg/L; sodium chloride 5000 to 9000 mg/L; disodium hydrogen phosphate 50 to 100 mg/L; sodium dihydrogen phosphate 50 to 100 mg/L; sodium selenite 20 to 100 mg/L;

[0055] shear force protective agent:

TABLE-US-00021 segmented polyether F68 500 to 2500 mg/L;

[0056] cell clustering resisting agent:

TABLE-US-00022 dextran sulfate 20 to 150 mg/L;

[0057] pH buffer agent:

TABLE-US-00023 sodium bicarbonate 1000 to 3000 mg/L;

[0058] pH indicator:

TABLE-US-00024 phenol red 5 to 15 mg/L;

[0059] influenza virus proliferation accelerant:

TABLE-US-00025 cholesterol 1 to 10 mg/L; DL-α-tocopherol acetate 0.3 to 3 mg/L; myristic acid 0.05 to 0.5 mg/L; palmitic acid 0.05 to 0.5 mg/L; stearic acid 0.05 to 0.5 mg/L; magnesium chloride 1000 to 5000 mg/L; calcium chloride 50 to 250 mg/L; dimethyl sulfoxide 2 to 20 mg/L; zinc sulfate 0.2 to 2.0 mg/L; copper sulfate 5 to 25 mg/L; manganese sulfate 0.0001 to 0.001 mg/L; ammonium metavanadate 0.001 to 0.005 mg/L;

[0060] other additives:

TABLE-US-00026 ammonium ferric citrate 13.5 to 40.5 mg/L; insulin 2 to 15 mg/L; soybean hydrolysate 1000 to 5000 mg/L; ethanolamine 1 to 10 mg/L; glutathione 0.5 to 3 mg/L.

[0061] The hypoxanthine and the thymidine are selected, in the nucleotide, so that the nucleotide synthesis of the MDCK cells can be promoted, and the, growth of the cells can be ensured; and if the proportion of the hypoxanthine and the thymidine is excessively high, the growth of the cells may be inhibited.

[0062] Ammonium ferric citrate is selected in other additives and used to substitute transferrin to play the original effect, the growth of the cells and the iron metabolism are not affected, animal protein components in the serum-free medium can be reduced, and the cost of the medium and the uncertainty and unsafety in production can be reduced; the ammonium ferric citrate absorbs iron through a divalent metal ion channel DMT1, while the transferrin absorbs the iron through a transferrin receptor, so that compared with the transferrin, the ammonium ferric citrate increases the absorption rate of the iron in the MDCK cells; if the concentration of the ammonium ferric citrate is excessively high, the growth of the MDCK cells may be inhibited; and if the concentration is excessively low, the MDCK cells are insufficient to absorb the iron.

[0063] The concentration of insulin in the other additives is 2 to 15 mg/L, so that the metabolism of the glucose can be promoted, the growth of the MDCK cells can be ensured and the activity of the MDCK cells can be maintained.

[0064] The concentration of the soybean hydrolysate in the other additives is 1000 to 5000 mg/mL, so that the supply of other auxiliary factors such as the vitamins, metal ions, amino acid and the like can be ensured, and the absorption of the amino acid in the MDCK cells can be improved.

[0065] A preparation method of a serum-free medium for full suspension culture of MDCK cells comprises the following steps:

[0066] 1) a mixed solution is prepared: raw materials are dissolved end mixed in one of the following methods:

[0067] I) raw materials are mixed and then ground into fine powder, and the obtained fine powder is dissolved in pyrogen-free ultra-pure water at 10 to 30° C. to obtain a mixed solution;

[0068] II) raw materials are respectively dissolved in the pyrogen-free ultra-pure water to obtain, a raw material solution; and then the obtained raw material solutions are mixed at the temperature of 10 to 30° C. to obtain a mixed solution; and

[0069] 2) pH is regulated: the sodium hydroxide is added to regulate the pH of the mixed solution to 6.3 to 6.7, and after a constant volume is set, the serum-free medium for the full suspension culture of the MDCK cells is obtained.

[0070] Specific embodiments

Embodiment 1

[0071] The present embodiment discloses a serum-free medium for full suspension culture of MDCK cells. The serum-free medium for the full suspension culture of the MDCK cells comprises components of the following concentrations: basic metabolic nutrients:

TABLE-US-00027 D-glucose 3715 mg/L; sodium pyruvate 110 mg/L; L-alanine 11.2 mg/L; L-arginine 219.1 mg/L; L-asparagine 22.6 mg/L; L-aspartic acid 22.2 mg/L; L-cystine 28.45 mg/L; L-cysteine 54.88 mg/L; L-glutamic acid 18.4 mg/L; L-glutamine 584 mg/L; glycine 13.22 mg/L; L-histidine 36.75 mg/L; L-isoleucine 44.76 mg/L; L-leucine 79.69 mg/L; L-lysine 85.77 mg/L; L-methionine 43.87 mg/L; L-phenylalanine 50.19 mg/L; L-proline 48.24 mg/L; L-serine 62.77 mg/L; L-threonine 85.29 mg/L; L-tryptophan 38.54 mg/L; L-tyrosine 45.50 mg/L; L-valine 58.11 mg/L;

[0072] nucleotide:

TABLE-US-00028 hypoxanthine 5.2 mg/L; thymidine 0.12 mg/L;  adenosine 3.5 mg/L; uridine 3.5 mg/L; cytidine 3.5 mg/L; guanosine 3.5 mg/L;

[0073] vitamins:

TABLE-US-00029 vitamin D 0.036 mg/L; folic acid 2.66 mg/L; nicotinamide 1.51 mg/L; pyridoxine 1.6 mg/L; thiamine 1.62 mg/L; riboflavin 0.18 mg/L; choline chloride 13 mg/L; D-calcium pantothenate 2.91 mg/L; inositol 12.5 mg/L;

[0074] inorganic salts:

TABLE-US-00030 ferric nitrate 24.19 mg/L; ferrous sulfate 0.417 mg/L; magnesium sulfate 24.4 mg/L; potassium chloride 311.8 mg/L; sodium chloride 5488 mg/L; disodium hydrogen phosphate 71 mg/L; sodium dihydrogen phosphate 62.5 mg/L; sodium selenite 25.94 mg/L;

[0075] shear force protective agent:

TABLE-US-00031 segmented polyether F68 1000 mg/L;

[0076] cell clustering resisting agent:

TABLE-US-00032 dextran sulfate 25 mg/L;

[0077] pH buffer agent:

TABLE-US-00033 sodium bicarbonate 2200 mg/L;

[0078] pH indicator:

TABLE-US-00034 phenol red 8 mg/L;

[0079] influenza virus proliferation

[0080] accelerant:

TABLE-US-00035 cholesterol 1.57 mg/L; DL-α-tocopherol acetate 0.7 mg/L; myristic acid 0.1142 mg/L; palmitic acid 0.128 mg/L; stearic acid 0.143 mg/L; magnesium chloride 1904 mg/L; calcium chloride 116.6 mg/L; dimethyl sulfoxide 5.5 mg/L; zinc sulfate 0.4 mg/L; copper sulfate 7.98 mg/L; manganese sulfate 0.000151 mg/L; ammonium metavanadate 0.00117 mg/L;

[0081] other additives:

TABLE-US-00036 ammonium ferric citrate 13.5 mg/L; insulin 5 mg/L; soybean hydrolysate 1400 mg/L; ethanolamine 1.73 mg/L; glutathione 0.7 mg/L.

[0082] The serum-free medium for the full suspension culture of MDCK cells is prepared according to the following steps:

[0083] 1) the raw materials are mixed and then ground into fine powder, the obtained fine powder is dissolved in pyrogen-free ultra-pure water at 10 to 30° C., the concentration of each raw material is as described above, and the mixed solution is obtained;

[0084] 2) the sodium hydroxide is added to regulate the pH of the mixed solution to 6.4, and after the constant volume is set, the serum-free medium DHN-1 for the full suspension culture of the MDCK cells is obtained.

Embodiment 2

[0085] According to the present embodiment, the serum-free medium for the full suspension culture of the MDCK cells comprises components of the following concentrations

[0086] basic metabolic nutrients:

TABLE-US-00037 D-glucose 4500 mg/L; sodium pyruvate 220 mg/L; L-alanine 22.3 mg/L; L-arginine 273.9 mg/L; L-asparagine 33.9 mg/L; L-aspartic acid 33.3 mg/L; L-cystine 42.67 mg/L; L-cysteine 68.60 mg/L; L-glutamic acid 36.8 mg/L; L-glutamine 876 mg/L; glycine 26.44 mg/L; L-histidine 73.50 mg/L; L-isoleucine 89.52 mg/L; L-leucine 159.38 mg/L; L-lysine 107.21 mg/L; L-methionine 87.74 mg/L; L-phenylalanine 100.38 mg/L; L-proline 96.47 mg/L; L-serine 78.46 mg/L; L-threonine 136.46 mg/L; L-tryptophan 57.81 mg/L; L-tyrosine 56.87 mg/L; L-valine 96.85 mg/L;

[0087] nucleotide:

TABLE-US-00038 hypoxanthine 10.3 mg/L; thymidine 0.24 mg/L; adenosine 7 mg/L; uridine 7 mg/L; cytidine 7 mg/L; guanosine 7 mg/L;

[0088] vitamins:

TABLE-US-00039 vitamin D 0.072 mg/L; folic acid 5.32 mg/L; nicotinamide 3.14 mg/L; pyridoxine 3.15 mg/L; thiamine 3.23 mg/L; riboflavin 0.36 mg/L; choline chloride 26.01 mg/L; D-calcium pantothenate 5.82 mg/L; inositol 25 mg/L;

[0089] inorganic salts:

TABLE-US-00040 ferric nitrate 24.19 mg/L; ferrous sulfate 0.417 mg/L; magnesium sulfate 48.8 mg/L; potassium chloride 311.8 mg/L; sodium chloride 6860 mg/L; disodium hydrogen phosphate 71 mg/L; sodium dihydrogen phosphate 62.5 mg/L; sodium selenite 51.88 mg/L;

[0090] shear force protective agent:

TABLE-US-00041 segmented polyether F68 1600 mg/L;

[0091] cell clustering resisting agent:

TABLE-US-00042 dextran sulfate 50 mg/L;

[0092] pH buffer agent:

TABLE-US-00043 sodium bicarbonate 2200 mg/L;

[0093] pH indicator:

TABLE-US-00044 phenol red 8 mg/L;

[0094] influenza virus proliferation accelerant:

TABLE-US-00045 cholesterol 3.13 mg/L; DL-α-tocopherol acetate 1.39 mg/L; myristic acid 0.2284 mg/L; palmitic acid 0.256 mg/L; stearic acid 0.285 mg/L; magnesium chloride 2856 mg/L; calcium chloride 174.9 mg/L; dimethyl sulfoxide 11 mg/L; zinc sulfate 0.8 mg/L; copper sulfate 15.97 mg/L; manganese sulfate 0.000302 mg/L; ammonium metavanadate 0.00234 mg/L;

[0095] other additives:

TABLE-US-00046 ammonium ferric citrate 27 mg/L; insulin 6.94 mg/L; soybean hydrolysate 2100 mg/L; ethanolamine 3.46 mg/L; glutathione 1.4 mg/L.

[0096] The serum-free medium for the full suspensor culture of the MDCK cells is prepared according to the following steps:

[0097] 1 ) the raw materials are mixed and then ground into fine powder, the obtained fine powder is dissolved in pyrogen-free ultra-pure water at 10 to 30° C., the concentration of each raw material is as described above, and the mixed solution is obtained: and

[0098] 2) the sodium hydroxide is added to regulate the pH of the mixed solution to 6.5, and after the constant volume is set, the serum-free medium DHN-2 for the full suspension culture of the MDCK cells is obtained.

Embodiment 3

[0099] According to the present embodiment, the serum-free medium for the full suspension culture of the MDCK cells comprises components of the following concentrations:

[0100] basic metabolic nutrients:

TABLE-US-00047 D-glucose 9000 mg/L; sodium pyruvate 440 mg/L; L-alanine 22.5 mg/L; L-arginine 547.8 mg/L; L-asparagine 45.2 mg/L; L-aspartic acid 55.5 mg/L; L-cystine 64.01 mg/L; L-cysteine 102.9 mg/L; L-glutamic acid 55.2 mg/L; L-glutamine 1460 mg/L; glycine 52.08 mg/L; L-histidine 110.25 mg/L; L-isoleucine 134.28 mg/L; L-leucine 239.07 mg/L; L-lysine 134.01 mg/L; L-methionine 109.68 mg/L; L-phenylalanine 200.76 mg/L; L-proline 144.71 mg/L; L-serine 117.69 mg/L; L-threonine 170.57 mg/L; L-tryptophan 77.07 mg/L; L-tyrosine 85.31 mg/L; L-valine 145.28 mg/L;

[0101] nucleotide:

TABLE-US-00048 hypoxanthine 20.6 mg/L; thymidine 0.48 mg/L; adenosine 10.5 mg/L; uridine 10.5 mg/L; cytidine 10.5 mg/L; guanosine 10.5 mg/L;

[0102] vitamins:

TABLE-US-00049 vitamin D 0.144 mg/L; folic acid 7.98 mg/L; nicotinamide 6.28 mg/L; pyridoxine 6.3 mg/L; thiamine 6.46 mg/L; riboflavin 0.72 mg/L; choline chloride 39.02 mg/L; D-calcium pantothenate 8.73 mg/L; inositol 37.5 mg/L;

[0103] inorganic salts:

TABLE-US-00050 ferric nitrate 24.19 mg/L; ferrous sulfate 0.417 mg/L; magnesium sulfate 73.2 mg/L; potassium chloride 311.8 mg/L; sodium chloride 8575 mg/L; disodium hydrogen 71 mg/L; phosphate sodium dihydrogen 62.5 mg/L; phosphate sodium selenite 77.82 mg/L;

[0104] shear force protective agent:

TABLE-US-00051 segmented polyether F68 2200 mg/L;

[0105] cell clustering resisting agent:

TABLE-US-00052 dextran sulfate 100 mg/L;

[0106] pH buffer agent:

TABLE-US-00053 sodium bicarbonate 2200 mg/L;

[0107] pH indicator:

TABLE-US-00054 phenol red 8 mg/L;

[0108] influenza virus proliferation accelerant:

TABLE-US-00055 cholesterol 6.26 mg/L; DL-α-tocopherol acetate 2.1 mg/L; myristic acid 0.3426 mg/L; palmitic acid 0.384 mg/L; stearic acid 0.428 mg/L; magnesium chloride 4762 mg/L; calcium chloride 233.2 mg/L; dimethyl sulfoxide 16.5 mg/L; zinc sulfate 1.6 mg/L; copper sulfate 23.96 mg/L; manganese sulfate 0.000453 mg/L; ammonium metavanadate 0.00351 mg/L;

[0109] other additives:

TABLE-US-00056 ammonium ferric citrate 40.5 mg/L; insulin 10.41 mg/L; soybean hydrolysate 4200 mg/L; ethanolamine 5.19 mg/L; glutathione 2.1 mg/L.

[0110] The serum-free medium for the full suspension culture of the MDCK cells is prepared according to the following, steps:

[0111] 1) the raw materials are mixed and then ground into fine powder, the obtained fine powder is dissolved in pyrogen-free ultra-pure water at 10 to 30° C., the concentration of each raw material is as described above, and the mixed solution is obtained;

[0112] 2) the sodium hydroxide is added to regulate the pH of the mixed solution to 6.7, and after the constant'volume is set, the serum-free medium DHN-3 for the full suspension culture of the MDCK cells is obtained.

[0113] A characteristic test is carried out for the medium obtained in embodiments 1 to 3:

[0114] 1. Instrument: bio-reactor Bio-Bundle purchased from Holland Applikon Biotechnology Company), and a volume of a tank body is 3L;

[0115] 2. Cells: MDCK cell lines suitable for the serum-free full suspension culture, provided by East China University of Science and Technology;

[0116] 3. Serum-free medium for reference: commercial serum-free medium SFM4 Mega Vir (purchased from Hyclone Company);

[0117] 4. Culture method: the cells are inoculated into the bio-reactor at a cell density of 0.5×10.sup.6 cells/mL and subjected to mass culture under the conditions of 37° C. and 5% CO.sub.2, the cells are sampled every 24 h for counting the living cells, and the growth rate of the cells is calculated. Results are shown in Table 1 and Table 2:

TABLE-US-00057 TABLE 1 Living cell density at different time (10.sup.6 cells/mL) Medium SFM4 Mega Vir Time (Reference) DHN-1 DHN-2 DHN-3 0 0.5 0.5 0.5 0.5 24 0.86 1.08 1.25 1.18 48 1.54 2.87 3.22 3.16 72 3.58 6.53 7.05 6.18 96 2.67 5.87 5.90 5.45

TABLE-US-00058 TABLE 2 Cell growth rate and doubling time Medium SFM4 Mega Vir Item (Reference) DHN-1 DHN-2 DHN-3 Average specific growth 0.57 0.80 0.91 0.77 rate of cells at a non-exponential growth period (d.sup.−1) Average doubling time of 0.79 0.39 0.32 0.43 cells at a non-exponential growth period (d)

[0118] Compared with the commercial serum-free medium SFM4 Mega Vir of a control group for the suspension culture of the MDCK cells, by adopting the serum-free medium provided by the present invention, the supported living cell density in the culture process is greatly increased; and furthermore, the specific, growth rate of the cells at the non-exponential growth period is increased from the maximum 0.57 d-1 of the control group to 0.91 d-1 in DHN-2 of the embodiment 2, and the doubling time of the cells is shortened from the maximum 0.79 d of the control group to 0.32 d in DHN-2 of the embodiment 2. It can be seen that by adopting the serum-free medium of the present invention to culture the MDCK cells, both the cell growth rate and the cell activity are greatly improved.

Embodiment 4

[0119] The serum-free medium DHN-2 prepared in embodiment 2 is used to perform the serum-free full suspension culture education for the serum adherent cultured MDCK cells. The cell education process is as follows:

[0120] 1) when the adherent MDCK cells cultured by DMEM containing 10% of new-born calf serum are cultured to the cell confluence of 80% to 90%, the original medium is abandoned, the cell layers are washed twice with pancreatin so as to neutralize the residual serum, and liquid is abandoned; a pancreatin solution is continuously added to cover the MDCK cells to perform the digestion for 5 to 15 min; after all cells become round, the digestion was terminated by adding medium containing 10% of fetal bovine serum with the volume four times of the volume of a digestive solution; and the cells are blown and beaten by using a pipette, the cells are suspended, a cell suspension solution is collected and centrifuged at 1000 rpm for 5 min, then supernatant is abandoned, and cell clusters are obtained;

[0121] 2) the cell clusters are re-suspended by using the serum-free medium DHN-2 until the cell density is about 1.5*10.sup.6 cells/mL, and a cell re-suspension solution is obtained;

[0122] 3) the cell re-suspension solution is added into a square vase and cultured in an incubator at :a rotation speed of 30 rpm, a temperature of 37° C., and 5% of CO.sub.2; after two-generation culture, the cultured cell re-suspension solution is transferred into a 125 mL of shake flask, and the rotation speed is increased to 120 rpm. The cells are sampled every 24 h, the sampled cells are counted and subjected to the activity analysis, the cell density is diluted with fresh medium DHN-2 to about 1.5*10.sup.6 cells/mL every 48 h, subculture is coontinued on a shaking table, and the MDCK cells suitable for the serum-free full suspension culture are obtained, and

[0123] 4) the living cell density and the cell activity are shown in FIG. 1: after the MDCK adherent cells are educated for 6 generations (13th day after the domestication) in the serum-free medium DHN-2, the cell growth is gradually stable, and the cell activity is kept at 95% or higher. Thus, it can prove that in the serum-free medium of the present invention, the MDCK adherent cells can be suitable for the suspension culture and grow stably only in two weeks, thereby greatly shortening the time for educating the MDCK cells from the adherent cells to the serum-free full suspension cells.

Embodiment 5

[0124] The morphology of the serum-free full suspension cultured MDCK cells educated with the medium of the present invention is compared with the morphology of the adherent culture cells and the cells cultured with other serum-free media, and results are shown in FIG. 2 to FIG. 5:

[0125] In FIG. 2, the MDCK cells in a serum adherent culture state are attached onto the surface of the medium and present a paving stone shape.

[0126] FIG. 3 illustrates the morphology of the full suspension cultured MDCK cells educated with the serum-free medium of the present invention, the cells present an individual scattering shape and have no clustering phenomenon, the cell morphology is complete, the boundary is smooth and clear, and the size is uniform.

[0127] FIG. 4 shows the suspension cultured MDCKS cells obtained by employing the serum-free medium SFM4 Mega Vir of Hyclone Company in a direct education method, and the picture is from Zhang Liangyan, Yao Zhidong et al. “Suspension Education and Primary Application of MDCK Cells”, biological technological communication, 2013, 24(3): 382-384, and it can be seen from the picture that a plurality of cells are clustered, individual cells are rare, and the cells are non-uniform in size.

[0128] FIG. 5 shows the MDCK.SUS2 cells obtained by employing the commercial serum-free medium SMIF8 developed by Gibco Company in an indirect education method; the picture is from: V. Lohr, Y. Genzel, et at. “A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor”. Vaccine.2010,28(3):6256-6264; and it can be seen from the picture that the morphology of the cells when in the suspension culture in the serum-free medium is also in a clustered shape, but the cluster is small, and the cells are non-uniform in size and bad in state.

[0129] Therefore, the adherent cultured MDCK cells are educated to the suspension culture state in the serum-free medium of the present invention, the cells grow in an individually scattering manner, the cell morphology is full and the size is uniform; and the cell quality is high.

[0130] It will be apparent to those skilled in the art that various other corresponding changes and variations may be made in accordance with the technical solutions and concepts described above, and all of the changes and variations shall belong to the protection scope of the claims of the present invention.